An in-depth look to EPS BIO TECHNOLOGY CORP operating, investing, and financing activities

4183 free cash flow for Q3 24 is -4.56 M TWD. For 2023, 4183 free cash flow was 45.69 M TWD and operating cash flow was 55.17 M TWD.